Literature DB >> 27283127

Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.

Ayhan Bilgiç1, Aysun Toker2, Saliha Uysal2.   

Abstract

AIM: Vasopressin exerts robust influences on social communication and behavior in humans. Apelin is a relatively novel neuropeptide that could counteract vasopressin's actions and has been shown to be closely related with a broad range of physiological functions. Abnormalities in vasopressin and apelin have been detected in a variety of psychiatric disorders, but their relation to attention-deficit hyperactivity disorder (ADHD) is unknown. In the present study, we explored the plasma levels of vasopressin and apelin-13 in children with ADHD.
METHODS: Thirty-four children with ADHD and 36 healthy controls were enrolled in this study. The severity of ADHD symptoms was assessed via Conners' Parent Rating Scale and Conners' Teacher Rating Scale. Plasma levels of vasopressin and apelin-13 were measured using commercial enzyme-linked immunosorbent assay kits.
RESULTS: The mean plasma apelin-13 levels were significantly higher in male children with ADHD than in male control subjects; no significant difference was found between the groups for plasma apelin-13 levels in girls or in the entire subject cohort. Plasma vasopressin levels did not show any significant differences between groups. There were no significant correlations between plasma levels of these neuropeptides and scores for Conners' Parent Rating Scale and Conners' Teacher Rating Scale.
CONCLUSION: Our results suggest a sex-specific association between plasma apelin-13 levels and ADHD. Apelin-13 may play a role in the etiopathogenesis of ADHD either with a direct impact on the apelin receptor or via its opposing effect on the vasopressinergic system.
© 2016 The Authors. Psychiatry and Clinical Neurosciences © 2016 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  apelin-13; attention-deficit hyperactivity disorder; children; plasma; vasopressin

Mesh:

Substances:

Year:  2016        PMID: 27283127     DOI: 10.1111/pcn.12415

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  2 in total

1.  Interaction of apelin, elabela and nitric oxide in schizophrenia patients.

Authors:  Zekiye Catak; Hilal Kaya; Esra Kocdemir; Kader Ugur; Guzel Saadet Pilten; Meltem Yardim; Ibrahim Sahin; Agirbas Esra Piril; Suleyman Aydin
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

Review 2.  New techniques, applications and perspectives in neuropeptide research.

Authors:  Kellen DeLaney; Amanda R Buchberger; Louise Atkinson; Stefan Gründer; Angela Mousley; Lingjun Li
Journal:  J Exp Biol       Date:  2018-02-08       Impact factor: 3.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.